Toward a Novel Metal-Based Chemotherapy against Tropical Diseases. 2. Synthesis and Antimalarial Activity in Vitro and in Vivo of New Ruthenium− and Rhodium−Chloroquine Complexes

Citations Over TimeTop 10% of 1996 papers

Abstract

Chloroquine free base (CQ) reacts with [Rh(COD)Cl]2 (COD = 1,5-cyclooctadiene) and RuCl3.-3H2O/Zn to yield Rh(COD)(CQ)Cl (1) and [RuCl2(CQ)]2 (2), respectively. The two novel metal- CQ complexes, which were characterized mainly by 1D and 2D NMR spectroscopy, were tested against Plasmodium berghei. The in vitro activity of 1 was comparable to that of chloroquine diphosphate (CQDP), whereas 2 was about 5 times more active. In in vivo tests at equivalent concentrations of free CQ, CQDP reduced the parasitemia by 55%, while for complexes 1 and 2 the reduction reached 73% and 94%, respectively, without any sign of acute toxicity being observed up to 30 days after treatment. The Ru derivative 2 was further evaluated against two chloroquine-resistant strains of Plasmodium falciparum, and it was found to be 2-5 times more active than CQDP.

Related Papers

• → Plasmodium berghei: Recombinant Interferon-γ and the Development of Parasitemia and Cerebral Lesions in Malaria-Infected Mice(1993)35 cited
• → Effect of Temperature and Clofibrate on Plasmodium Berghei Infection in Mice(1979)8 cited
• → Effects of Lowered Environmental Temperature on the Growth of Exoerythrocytic Stages of Plasmodium Berghei(1975)5 cited
• → Correlation of Parasitaemia and Anemia in Mice Infected with Plasmodium berghei ANKA(2023)1 cited
• → Chloroquine Sensitivity and Pigment Formation in Rodent Malaria(1969)18 cited